Biologic degraders push forward in the clinic

Written By Jamison Wright

https://www.nature.com/articles/d41573-026-00064-y

Jamison Wright https://jamisonwright.com
Next

EpiBiologics Doses First Patient with EPI-326 Bispecific Antibody in Global Phase 1 Study for EGFR-Driven Solid Tumors